銀休特 PODD 深 滬
已收盤 08-07 16:00:00 美东时间
141.17
+1.870
+1.34%
華盛通- 最 高142.22
- 今 開138.00
- 成交量 159.13万股
- 最 低 136.46
- 昨 收 139.30
- 總市值 97.78亿
- 52周最高 354.88
- 市盈率 靜 40.58
- 換手率 2.30%
- 52周最低 126.40
- 委 比 71.09%
- 總股本 6926.47万
- 歷史最高 354.88
- 量 比 0.53
- 振 幅 4.13%
- 歷史最低 14.00
- 每 手 1
- 風險率 69.37%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
These Analysts Slash Their Forecasts On Insulet After Q2 Results
Insulet Corp. (NASDAQ:PODD) on Wednesday posted upbeat second-quarter results but lowered its full-year revenue guidance. Adjusted earnings rose to $1.66 per share from $1.17 a year earlier, beating the analyst consensus estimate of $1.45. Revenue increased 23.5% year over year to $801.7 million, to...
08-06 19:28
BTIG Downgrades Insulet to Neutral
BTIG analyst Marie Thibault downgrades Insulet (NASDAQ:PODD) from Buy to Neutral.
08-06 18:05
Truist Securities Downgrades Insulet to Hold, Lowers Price Target to $153
Truist Securities analyst Richard Newitter downgrades Insulet (NASDAQ:PODD) from Buy to Hold and lowers the price target from $210 to $153.
08-06 17:47
财报速睇 | 银休特 2026财年Q2营收8.02亿美元，同比增长23.5%；归母净利润0.95亿美元，同比增长322.2%
华盛资讯8月6日讯，银休特公布2026财年Q2业绩，公司Q2营收8.02亿美元，同比增长23.5%，归母净利润0.95亿美元，同比增长322.2%。
08-06 10:36
Insulet downgraded at Oppenheimer on growing risks
Oppenheimer lowered Insulet (PODD) to perform from outperform, citing growing risks from a softer-than-expected growth outlook. The bank also removed its price target. The downgrade came as the insuli...
08-06 02:52
Insulet sends Tandem, DexCom lower after guidance cut
Shares of Insulet Corporation (PODD) reached a new 52-week low on Wednesday after the insulin pump maker lowered its full-year revenue outlook, sending its rival Tandem Diabetes (TNDM) and glucose mon...
08-05 22:44
Omnipod Sales Soar, But Insulet's Outlook Cut Sparks Stock Selloff
Insulet Corp. (NASDAQ:PODD) stock traded lower Wednesday after the insulin pump maker reported second-quarter results that topped Wall Street expectations but lowered its full-year revenue guidance and issued third-quarter sales guidance that came in below analysts’ estimates. Adjusted earnings rose...
08-05 19:58
财报速睇 | 银休特 2026财年Q2营收8.02亿美元，同比增长23.5%；归母净利润0.95亿美元，同比增长322.2%
华盛资讯8月5日讯，银休特公布2026财年Q2业绩，公司Q2营收8.02亿美元，同比增长23.5%，归母净利润0.95亿美元，同比增长322.2%。
08-05 19:24
Insulet Sees Q3 Sales $829.903M-$844.029M vs $845.476M Est
Insulet (NASDAQ:PODD) sees Q3 sales of $829.903 million-$844.029 million vs $845.476 million analyst estimate.
08-05 19:07
